N/A N=99 Randomized Treatment

Laparoscopic Complete Mesocolic Excision on Colon Cancer

Operation Finding · Complications · Pathology · Quality of Life · Neoplasms Recurrence

Bottom Line

View on ClinicalTrials.gov: NCT01628250 ↗

Enrolled (actual)

Serious AEs

31.3%

Results posted

Jun 2016

Primary outcome: Primary: Histopathological Outcomes Obtained Through the Surgeries — 20.3; 19.2 nodes

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: laparoscopic complete mesocolic excision (Procedure); D3-laparoscopic colectomy (Procedure)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Bo Feng
Primary completion: Oct 2015

Outcome Measures

Outcome	Result	p-value
PRIMARY Histopathological Outcomes Obtained Through the Surgeries	20.3; 19.2	—
SECONDARY Survival Rate	—	—

Summary

Laparoscopic complete mesocolic excision is a concept that using laparoscopic surgery technique to perform a resection for colon cancer. Besides, the segment of the colon containing the tumor, the resection area should include an intact mesocolon as an envelope to encase the possible route for metastasis. The routes include blood vessels, lymphatic drain and etc. Such hypothesis predicts better histopathological and higher oncological results which turns into better survival rate and better quality of life.

Eligibility Criteria

Inclusion Criteria

Patients with pathologically confirmed colon cancer
Signed consent

Exclusion Criteria

History of malignancy
Intestinal obstruction or perforation
Evidence of metastasis by preoperative examinations
Deformity of spine
Emergency case
BMI > 29

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01628250). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.